Apollomics Alternatives & Competitors
12 companies similar to Apollomics — We are a biopharmaceutical company committed to the discovery and development of...
Companies similar to Apollomics
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Glycyx
Restoring immune response in cancer: reversing Opioid-Induced Immunodeficiency to enhance...
Surface Oncology Inc.
#lifeunderthesurface #BBJBestPlacesToWork2023,2022,2021 #BostonGlobeTopPlacesToWork2023,2...
ImmunoCellular Therapeutics Ltd
Pioneering immune-based therapies to harness the body's defenses against cancer through ad...
Rival Readout
Competing with Apollomics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Curis
Working relentlessly to develop innovative and differentiated therapeutics that improve th...
Genprex, Inc.
Genprex is a gene therapy company focused on developing life-changing technologies for pat...
BeyondSpring
Based in Duncan, South Carolina, we are a pioneering biotechnology company dedicated to ad...
Elevation Oncology
We are focused on discovering and developing selective cancer therapies to treat patients...
TME Pharma
Developing novel therapies for treatment of the most aggressive cancers by acting on the t...
Oxford BioTherapeutics
Redefining the cancer-immune synapse for novel immune checkpoint mechanisms
TransCode Therapeutics, Inc.
Delivering a cancer-free future
GLG Pharma
Why Show the GSK Compound? Because the cancer cells become resistant. How? By STAT3! GLG's...
About Apollomics
Apollomics is a biopharmaceutical company with a clear mission to discover and develop mono- and combination cancer therapies. Established in 2016, Apollomics has made strategic moves to operate in both the U.S. and China, aiming to harness synergies by collaborating with biotechnology companies in both the East and th...
Biopharmaceutical Company, Oncology Therapies, Combination Therapies, Cancer Treatment, Drug Development, Immune System, Molecular Pathways, Clinical Trials, Immunotherapy, Monoclonal Antibodies, Targeted Therapies, Cancer Research, Drug Candidates, Pharmaceutical Pipeline
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Apollomics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Apollomics on 12 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.